SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indoco Remedies - Quaterly Results

23 Jul 2024 Evaluate
The sales declined to Rs. 4014.30 millions for the June 2024 quarter as compared to Rs. 4228.80 millions during the corresponding quarter last year.A big decline of -42.37% was reported for the quarter ended June 2024 to Rs. 149.50  millions from Rs. 259.40 millions of corresponding previous quarter.The company reported a degrowth in operating Profit to 550.90 millions from 633.20 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 4014.30 4228.80 -5.07 4014.30 4228.80 -5.07 17908.10 16666.90 7.45
Other Income 35.20 4.10 758.54 35.20 4.10 758.54 85.10 23.30 265.24
PBIDT 550.90 633.20 -13.00 550.90 633.20 -13.00 2664.90 2872.20 -7.22
Interest 118.80 77.80 52.70 118.80 77.80 52.70 368.20 250.30 47.10
PBDT 432.10 555.40 -22.20 432.10 555.40 -22.20 2412.00 2621.90 -8.01
Depreciation 237.00 198.70 19.28 237.00 198.70 19.28 879.80 706.00 24.62
PBT 195.10 356.70 -45.30 195.10 356.70 -45.30 1532.20 1915.90 -20.03
TAX 45.60 97.30 -53.13 45.60 97.30 -53.13 365.80 502.30 -27.17
Deferred Tax -1.70 11.80 -114.41 -1.70 11.80 -114.41 38.10 -49.70 -176.66
PAT 149.50 259.40 -42.37 149.50 259.40 -42.37 1166.40 1413.60 -17.49
Equity 184.40 184.30 0.05 184.40 184.30 0.05 184.40 184.30 0.05
PBIDTM(%) 13.72 14.97 -8.35 13.72 14.97 -8.35 14.88 17.23 -13.65

Indoco Remedies Share Price

219.40 -8.80 (-3.86%)
11-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1872.40
Dr. Reddys Lab 1279.70
Cipla 1304.70
Zydus Lifesciences 956.65
Lupin 2245.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×